🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Role of Interoceptive Sensitivity in Central Sensitization Symptom Severity in Fibromyalgia

Recruitingn/aAges 18 Years - 65 YearsFemaleSultan Abdulhamid Han Training and Research Hospi…
NCT07878286 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In fibromyalgia, the increased central sensitization symptom burden can lead to a disruption in the individual's interoception and difficulties in managing symptoms. Additionally, impaired internal perception can also affect conditions such as pain severity, fatigue, sleep quality, and accompanying depression and anxiety in fibromyalgia patients. With this study, the relationship between central sensitization and interoceptive sensitivity in fibromyalgia will be examined, and the relationship of interoceptive sensitivity with issues such as sleep quality, pain severity, fatigue, anxiety, and depression in fibromyalgia patients will also be investigated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women patients aged 18-65 * Diagnosed with fibromyalgia according to the 2016 ACR criteria * Experiencing widespread pain for at least 3 months * Having the cognitive ability to complete the scales * Having read and signed the informed consent form (ICF) Exclusion Criteria: * Being under 18 or over 65 years old * Pregnancy * Active inflammatory rheumatic disease * Neurological disease * Malignancy * Severe psychiatric disorder * Serious systemic disease such as heart or kidney failure
💊

What it tests

  • Central Sensitization Inventory
  • The Multidimensional Assessment of Interoceptive Awareness scale-2
  • Revised Fibromyalgia Impact Questionnaire
  • Numeric rating scale
  • Hospital Anxiety and Depression Scale
📍

Where

1 site
Sultan Abdülhamid Han Eğitim ve Araştırma Hastanesi
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy